Estradiol enantate

http://dbpedia.org/resource/Estradiol_enantate an entity of type: Thing

에스트라디올 에난테이트(Estradiol enantate, E2-En 또는 EEn)는 여성의 호르몬적 산아 제한에 사용되는 에스트로겐 약물이다. DHPA와 함께 복합해서 사용하는 경우 한 달에 한 차례씩 근육 주사를 통해 투여되게 된다. rdf:langString
Estradiol enantate (EEn or E2-EN), also spelled estradiol enanthate and sold under the brand names Perlutal and Topasel among others, is an estrogen medication which is used in hormonal birth control for women. It is formulated in combination with dihydroxyprogesterone acetophenide (DHPA; algestone acetophenide), a progestin, and is used specifically as a combined injectable contraceptive. Estradiol enantate is not available for medical use alone. The medication, in combination with DHPA, is given by injection into muscle once a month. rdf:langString
rdf:langString Estradiol enantate
rdf:langString 에스트라디올 에난테이트
xsd:integer 25857669
xsd:integer 1120786206
rdf:langString CA03
rdf:langString G03
rdf:langString : High
xsd:integer 25
xsd:integer 4956
xsd:integer 1697792
xsd:integer 19815
<second> -648000.0
xsd:integer 36
rdf:langString Estradiol enanthate molecule ball.png
rdf:langString [-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] heptanoate
rdf:langString D04064
rdf:langString Rx-only
rdf:langString Cleavage via esterases in the liver, blood, and tissues
xsd:integer 3
xsd:integer 21070
rdf:langString CCCCCCCO[C@H]1CC[C@@H]2[C@@]1C
xsd:integer 1
rdf:langString RFWTZQAOOLFXAY-BZDYCCQFSA-N
rdf:langString EEn; E2-EN; EE; E2E; Estradiol enanthate; Estradiol heptanoate; SQ-16150
rdf:langString Perlutal, Topasel, Unalmes, Yectames, others
rdf:langString PAP315WZIA
xsd:integer 250
rdf:langString Estradiol enantate (EEn or E2-EN), also spelled estradiol enanthate and sold under the brand names Perlutal and Topasel among others, is an estrogen medication which is used in hormonal birth control for women. It is formulated in combination with dihydroxyprogesterone acetophenide (DHPA; algestone acetophenide), a progestin, and is used specifically as a combined injectable contraceptive. Estradiol enantate is not available for medical use alone. The medication, in combination with DHPA, is given by injection into muscle once a month. Side effects of estradiol enantate include breast tenderness, breast enlargement, nausea, headache, and fluid retention. Estradiol enantate is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. It is an estrogen ester and a long-lasting prodrug of estradiol in the body. Because of this, it is considered to be a natural and bioidentical form of estrogen. Estradiol enantate was first described by 1954, and was first studied in combination with DHPA as a combined injectable contraceptive in 1964. The combination was introduced for clinical use by the mid-1970s. Estradiol enantate is not available as a standalone medication (i.e., by itself without DHPA). The combination is available in Latin America and Hong Kong, and was also previously marketed in Spain and Portugal.
rdf:langString 에스트라디올 에난테이트(Estradiol enantate, E2-En 또는 EEn)는 여성의 호르몬적 산아 제한에 사용되는 에스트로겐 약물이다. DHPA와 함께 복합해서 사용하는 경우 한 달에 한 차례씩 근육 주사를 통해 투여되게 된다.
<second> -2592000.0
rdf:langString Estradiol, heptanoic acid, and metabolites of estradiol
rdf:langString Estradiol: ~98%
xsd:nonNegativeInteger 55295
rdf:langString Perlutal, Topasel, Unalmes, Yectames, others
xsd:string 4956-37-0
xsd:string 1697792
xsd:string PAP315WZIA
xsd:string D04064
xsd:string 21070

data from the linked data cloud